vs
LINDBLAD EXPEDITIONS HOLDINGS, INC.（LIND）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是LINDBLAD EXPEDITIONS HOLDINGS, INC.的1.1倍（$207.3M vs $183.2M），LINDBLAD EXPEDITIONS HOLDINGS, INC.净利率更高（-12.9% vs -62.0%，领先49.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 23.3%），LINDBLAD EXPEDITIONS HOLDINGS, INC.自由现金流更多（$3.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 9.2%）
林德布拉德探险控股是一家专业探险旅行企业，总部位于美国纽约。目前公司运营15艘探险邮轮，载客量从28人到150人不等，可为旅行者提供覆盖全球七大洲目的地的探险邮轮旅程。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LIND vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.2M | $207.3M |
| 净利润 | $-23.6M | $-128.6M |
| 毛利率 | 40.3% | — |
| 营业利润率 | -3.0% | -54.7% |
| 净利率 | -12.9% | -62.0% |
| 营收同比 | 23.3% | 25.9% |
| 净利润同比 | 6.0% | 3.5% |
| 每股收益（稀释后） | $-0.45 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $183.2M | $207.3M | ||
| Q3 25 | $240.2M | $159.9M | ||
| Q2 25 | $167.9M | $166.5M | ||
| Q1 25 | $179.7M | $139.3M | ||
| Q4 24 | $148.6M | $164.6M | ||
| Q3 24 | $206.0M | $139.5M | ||
| Q2 24 | $136.5M | $147.0M | ||
| Q1 24 | $153.6M | $108.8M |
| Q4 25 | $-23.6M | $-128.6M | ||
| Q3 25 | $1.2M | $-180.4M | ||
| Q2 25 | $-8.5M | $-115.0M | ||
| Q1 25 | $1.2M | $-151.1M | ||
| Q4 24 | $-25.0M | $-133.2M | ||
| Q3 24 | $22.5M | $-133.5M | ||
| Q2 24 | $-24.7M | $-131.6M | ||
| Q1 24 | $-4.0M | $-170.7M |
| Q4 25 | 40.3% | — | ||
| Q3 25 | 48.2% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 48.3% | — | ||
| Q4 24 | 42.5% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 39.2% | — | ||
| Q1 24 | 45.0% | — |
| Q4 25 | -3.0% | -54.7% | ||
| Q3 25 | 15.0% | -106.9% | ||
| Q2 25 | 2.6% | -64.8% | ||
| Q1 25 | 5.9% | -102.6% | ||
| Q4 24 | -5.1% | -74.3% | ||
| Q3 24 | 14.3% | -94.6% | ||
| Q2 24 | -6.0% | -79.1% | ||
| Q1 24 | 5.1% | -151.9% |
| Q4 25 | -12.9% | -62.0% | ||
| Q3 25 | 0.5% | -112.8% | ||
| Q2 25 | -5.1% | -69.0% | ||
| Q1 25 | 0.6% | -108.5% | ||
| Q4 24 | -16.9% | -80.9% | ||
| Q3 24 | 10.9% | -95.7% | ||
| Q2 24 | -18.1% | -89.5% | ||
| Q1 24 | -2.6% | -156.8% |
| Q4 25 | $-0.45 | $-1.28 | ||
| Q3 25 | $0.00 | $-1.81 | ||
| Q2 25 | $-0.18 | $-1.17 | ||
| Q1 25 | $0.00 | $-1.57 | ||
| Q4 24 | $-0.45 | $-1.34 | ||
| Q3 24 | $0.36 | $-1.40 | ||
| Q2 24 | $-0.48 | $-1.52 | ||
| Q1 24 | $-0.10 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.7M | $421.0M |
| 总债务越低越好 | $662.7M | — |
| 股东权益账面价值 | $-284.5M | $-80.0M |
| 总资产 | $980.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $256.7M | $421.0M | ||
| Q3 25 | $261.8M | $202.5M | ||
| Q2 25 | $200.9M | $176.3M | ||
| Q1 25 | $188.9M | $127.1M | ||
| Q4 24 | $183.9M | $174.0M | ||
| Q3 24 | $193.9M | $150.6M | ||
| Q2 24 | $168.1M | $480.7M | ||
| Q1 24 | $177.7M | $112.3M |
| Q4 25 | $662.7M | — | ||
| Q3 25 | $663.5M | — | ||
| Q2 25 | $627.3M | — | ||
| Q1 25 | $626.4M | — | ||
| Q4 24 | $625.5M | — | ||
| Q3 24 | $624.5M | — | ||
| Q2 24 | $623.6M | — | ||
| Q1 24 | $622.7M | — |
| Q4 25 | $-284.5M | $-80.0M | ||
| Q3 25 | $-256.6M | $9.2M | ||
| Q2 25 | $-263.8M | $151.3M | ||
| Q1 25 | $-252.2M | $144.2M | ||
| Q4 24 | $-253.1M | $255.0M | ||
| Q3 24 | $-226.9M | $346.8M | ||
| Q2 24 | $-255.5M | $432.4M | ||
| Q1 24 | $-227.4M | $140.3M |
| Q4 25 | $980.0M | $1.5B | ||
| Q3 25 | $976.5M | $1.2B | ||
| Q2 25 | $936.5M | $1.3B | ||
| Q1 25 | $908.8M | $1.3B | ||
| Q4 24 | $876.9M | $1.5B | ||
| Q3 24 | $889.8M | $1.5B | ||
| Q2 24 | $858.3M | $1.6B | ||
| Q1 24 | $868.0M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 1.9% | -48.6% |
| 资本支出强度资本支出/营收 | 6.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $63.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $14.4M | $-99.8M | ||
| Q3 25 | $19.5M | $-91.4M | ||
| Q2 25 | $29.2M | $-108.3M | ||
| Q1 25 | $48.4M | $-166.5M | ||
| Q4 24 | $1.7M | $-79.3M | ||
| Q3 24 | $28.1M | $-67.0M | ||
| Q2 24 | $18.6M | $-77.0M | ||
| Q1 24 | $43.9M | $-190.7M |
| Q4 25 | $3.5M | $-100.8M | ||
| Q3 25 | $11.9M | $-92.7M | ||
| Q2 25 | $13.5M | $-110.7M | ||
| Q1 25 | $35.0M | $-167.8M | ||
| Q4 24 | $-8.2M | $-79.5M | ||
| Q3 24 | $18.4M | $-68.6M | ||
| Q2 24 | $11.2M | $-79.0M | ||
| Q1 24 | $37.4M | $-193.9M |
| Q4 25 | 1.9% | -48.6% | ||
| Q3 25 | 5.0% | -58.0% | ||
| Q2 25 | 8.0% | -66.5% | ||
| Q1 25 | 19.5% | -120.5% | ||
| Q4 24 | -5.5% | -48.3% | ||
| Q3 24 | 8.9% | -49.2% | ||
| Q2 24 | 8.2% | -53.7% | ||
| Q1 24 | 24.4% | -178.2% |
| Q4 25 | 6.0% | 0.5% | ||
| Q3 25 | 3.2% | 0.8% | ||
| Q2 25 | 9.4% | 1.5% | ||
| Q1 25 | 7.5% | 1.0% | ||
| Q4 24 | 6.6% | 0.1% | ||
| Q3 24 | 4.7% | 1.2% | ||
| Q2 24 | 5.4% | 1.4% | ||
| Q1 24 | 4.2% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 16.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 41.69× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIND
| Guest Ticket | $96.5M | 53% |
| Landexperience | $67.3M | 37% |
| Other Tour | $19.4M | 11% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
